iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Nifty Pharma sinks 1%; Gland Pharma gains 7% while Granules, Aurobindo Pharma top laggards

25 Jan 2023 , 06:41 PM

The Nifty Pharma sank over 1% tracking weak markets on Wednesday. Gland Pharma led the gains being the top performer on the index while Granules tumbled 6%.

The Indian equity benchmarks plunged sharply on Wednesday as global markets slipped. At around 10:50 AM, Nifty50 was trading at 17,919.40 down 198.90 points or 1.10% and BSE Sensex at 60,336.08 down 642.67 points or 1.05%.

The Nifty Pharma was trading at 12,467.80 down 126.05 points or 1%, touching a high of 12,594.50 and low of 12,443.20 during intraday trade on Wednesday.

Gland Pharma surged over 7% at Rs1,451.21 per share to emerge among the top two overall gainers list. The pharma major has reported a 15 percent on-year decline in profit at Rs 232 crore for December FY23 quarter with lower topline as well as weak operating performance.

Glaxosmithkline Pharmaceuticals was also 0.4% higher to be the only second listed company on NSE to trade in the green on Wednesday.

Granules shed over 6% at Rs290.65 per share. Aurobindo Pharma also was 4% lower. Biocon (down 3.3%), Glenmark (down 2.5%), Zydus Life (down 1.8%), Laurus Labs (down 1.5%), Abbott and Dr Reddy’s (down 1.4% each), Lupin (down 1.3%), Ipca Lab (down 1.2%) and Cipla (down 1.06%) also made significant losses on Wednesday. 

Further, Torrent Pharma, Divis Lab, Pfizer, Natco Pharma, Sun Pharma, Alkem and Sanofi also dragged the overall sector by plunging between 1-0.3%.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Aurobindo Pharma share price
  • Biocon share price
  • Cadila Healthcare share price
  • Cipla share price
  • Coronavirus vaccine
  • Dr Reddys share price
  • Live commentary
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Top Stocks for Today - 30th April 2025
30 Apr 2025|06:17 AM
Fino Payments Bank FY25 Profit Jumps 26%
29 Apr 2025|11:48 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.